The increasing problem of subclinical and overt hypervitaminosis D in India: An institutional experience and review

Nutrition

Volumn 34, Issue , 2017, Pages 76-81

  Sharma, Lokesh Kumar ^a   Dutta, Deep ^a   Sharma, Neera ^a   Gadpayle, Adesh Kisanji ^a  

^a DR RAM MANOHAR LOHIA HOSPITAL   (India)

Author keywords

Deficiency; Hypervitaminosis; Intoxication; Toxicity; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; PARATHYROID HORMONE; VITAMIN D;

ADULT; ARTICLE; AUSTRALIA; CANADA; ENGLAND; FEMALE; HUMAN; INDIA; IRELAND; MAJOR CLINICAL STUDY; MALE; ORTHOPEDICS; PEDIATRICS; PRIORITY JOURNAL; VITAMIN D DEFICIENCY; VITAMIN D INTOXICATION; BLOOD; DIETARY SUPPLEMENT; DOSE RESPONSE; FACTUAL DATABASE; NUTRITION DISORDERS; PREVALENCE; SEASON;

CALCIUM; DATABASES, FACTUAL; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INDIA; NUTRITION DISORDERS; PARATHYROID HORMONE; PREVALENCE; SEASONS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 85009142182     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2016.09.014     Document Type: Article

References (43)

1. [1] Dutta, D., Maisnam, I., Shrivastava, A., Sinha, A., Ghosh, S., Mukhopadhyay, P., et al. Serum vitamin-D predicts insulin resistance in individuals with prediabetes. Indian J Med Res 138 (2013), 121–128.
2. [2] Sahu, M., Bhatia, V., Aggarwal, A., Rawat, V., Saxena, P., Pandey, A., et al. Vitamin D deficiency in rural girls and pregnant women despite abundant sunshine in northern India. Clin Endocrinol (Oxf) 70 (2009), 680–684.
3. [3] Dutta, D., Mondal, S.A., Choudhuri, S., Maisnam, I., Hasanoor Reza, A.H., Bhattacharya, B., et al. Vitamin-D supplementation in prediabetes reduced progression to type 2 diabetes and was associated with decreased insulin resistance and systemic inflammation: an open label randomized prospective study from Eastern India. Diabetes Res Clin Pract 103 (2014), e18–e23.
4. [4] Dutta, D., Choudhuri, S., Mondal, S.A., Mukherjee, S., Chowdhury, S., Urinary albumin:creatinine ratio predicts prediabetes progression to diabetes and reversal to normoglycemia: role of associated insulin resistance, inflammatory cytokines and low vitamin D. J Diabetes 6 (2014), 316–322.
5. [5] Kaur, P., Mishra, S.K., Mithal, A., Vitamin D toxicity resulting from overzealous correction of vitamin D deficiency. Clin Endocrinol (Oxf) 83 (2015), 327–331.
6. [6] Holick, M.F., Binkley, N.C., Bischoff-Ferrari, H.A., Gordon, C.M., Hanley, D.A., Heaney, R.P., et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 96 (2011), 1911–1930.
7. [7] McKenna, M.J., Murray, B.F., O'Keane, M., Kilbane, M.T., Rising trend in vitamin D status from 1993 to 2013: dual concerns for the future. Endocr Connect 4 (2015), 163–171.
8. [8] Jorde, R., Sneve, M., Hutchinson, M., Emaus, N., Figenschau, Y., Grimnes, G., Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am J Epidemiol 171 (2010), 903–908.
9. [9] Berger, C., Greene-Finestone, L.S., Langsetmo, L., Kreiger, N., Joseph, L., Kovacs, C.S., et al. Temporal trends and determinants of longitudinal change in 25-hydroxyvitamin D and parathyroid hormone levels. J Bone Miner Res 27 (2012), 1381–1389.
10. [10] French, D., Gorgi, A.W., Ihenetu, K.U., Weeks, M.A., Lynch, K.L., Wu, A.H., Vitamin D status of county hospital patients assessed by the DiaSorin LIAISON® 25-hydroxyvitamin D assay. Clin Chim Acta 412 (2011), 258–262.
11. [11] Bilinski, K., Boyages, S., The rise and rise of vitamin D testing. BMJ, 345, 2012, e4743.
12. [12] Sattar, N., Welsh, P., Panarelli, M., Forouhi, N.G., Increasing requests for vitamin D measurement: costly, confusing, and without credibility. Lancet 379 (2012), 95–96.
13. [13] Quaggiotto, P., Tran, H., Bhanugopan, M., Vitamin D deficiency remains prevalent despite increased laboratory testing in New South Wales, Australia. Singapore Med J 55 (2014), 271–280.
14. [14] Dudenkov, D.V., Yawn, B.P., Oberhelman, S.S., Fischer, P.R., Singh, R.J., Cha, S.S., et al. Changing incidence of serum 25-hydroxyvitamin D values above 50 ng/mL: a 10-year population-based study. Mayo Clin Proc 90 (2015), 577–586.
15. [15] Khan, A.H., Majid, H., Iqbal, R., Shifting of vitamin D deficiency to hypervitaminosis and toxicity. J Coll Physicians Surg Pak, 24, 2014, 536.
16. [16] Genzen, J.R., Gosselin, J.T., Wilson, T.C., Racila, E., Krasowski, M.D., Analysis of vitamin D status at two academic medical centers and a national reference laboratory: result patterns vary by age, gender, season, and patient location. BMC Endocr Disord, 13, 2013, 52.
17. [17] Hawkes, C.P., Schnellbacher, S., Singh, R.J., Levine, M.A., 25-hydroxyvitamin D can interfere with a common assay for 1,25-dihydroxyvitamin D in vitamin D intoxication. J Clin Endocrinol Metab 100 (2015), 2883–2889.
18. [18] Spiller, H.A., Good, T.F., Spiller, N.E., Aleguas, A., Vitamin D exposures reported to US poison centers 2000–2014: temporal trends and outcomes. Hum Exp Toxicol 35 (2016), 457–461.
19. [19] Taylor, C.L., Carriquiry, A.L., Bailey, R.L., Sempos, C.T., Yetley, E.A., Appropriateness of the probability approach with a nutrient status biomarker to assess population inadequacy: a study using vitamin D. Am J Clin Nutr 97 (2013), 72–78.
20. [20] Melamed, M.L., Michos, E.D., Post, W., Astor, B., 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 168 (2008), 1629–1637.
21. [21] Amrein, K., Quraishi, S.A., Litonjua, A.A., Gibbons, F.K., Pieber, T.R., Camargo, C.A. Jr., et al. Evidence for a U-shaped relationship between pre-hospital vitamin D status and mortality: a cohort study. J Clin Endocrinol Metab 99 (2014), 1461–1469.
22. [22] Durup, D., Jørgensen, H.L., Christensen, J., Schwarz, P., Heegaard, A.M., Lind, B., A reverse J-shaped association of all-cause mortality with serum 25-hydroxyvitamin D in general practice: The CopD study. J Clin Endocrinol Metab 97 (2012), 2644–2652.
23. [23] Ginde, A.A., Scragg, R., Schwartz, R.S., Camargo, C.A. Jr., Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc 57 (2009), 1595–1603.
24. [24] Fiscella, K., Franks, P., Vitamin D, race, and cardiovascular mortality: findings from a national US sample. Ann Fam Med 8 (2010), 11–18.
25. [25] Chlebowski, R.T., Johnson, K.C., Kooperberg, C., Pettinger, M., Wactawski-Wende, J., Rohan, T., et al. Women's Health Initiative investigators. Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst 100 (2008), 1581–1591.
26. [26] Tuohimaa, P., Tenkanen, L., Ahonen, M., Lumme, S., Jellum, E., Hallmans, G., et al. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int J Cancer 108 (2004), 104–108.
27. [27] Ross, A.C., Manson, J.E., Abrams, S.A., Aloia, J.F., Brannon, P.M., Clinton, S.K., et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96 (2011), 53–58.
28. [28] Rosen, C.J., Abrams, S.A., Aloia, J.F., Brannon, P.M., Clinton, S.K., Durazo-Arvizu, R.A., et al. IOM Committee members respond to Endocrine Society vitamin D guideline. J Clin Endocrinol Metab 97 (2012), 1146–1152.
29. [29] McKenna, M.J., Murray, B.F., Vitamin D dose response is underestimated by Endocrine Society's Clinical Practice Guideline. Endocr Connect 2 (2013), 87–95.
30. [30] Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Dietary reference intakes for calcium, phosphorus, magnesium, vitamin d and fluoride. 1997, National Academies Press, Washington, DC, 250–287.
31. [31] Gahche, J., Bailey, R., Burt, V., Hughes, J., Yetley, E., Dwyer, J., et al. Dietary supplement use among U.S. adults has increased since NHANES III (1988-1994). NCHS Data Brief 61 (2011), 1–8.
32. [32] Blank, S., Scanlon, K.S., Sinks, T.H., Lett, S., Falk, H., An outbreak of hypervitaminosis D associated with the overfortification of milk from a home-delivery dairy. Am J Public Health 85 (1995), 656–659.
33. [33] Virmani, A., Vitamin D toxicity. Indian Pediatr, 51, 2014, 63.
34. [34] Misra, M., Pacaud, D., Petryk, A., Collett-Solberg, P.F., Kappy, M., Drug and therapeutics committee of the Lawson Wilkins Pediatric Endocrine Society. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 122 (2008), 398–417.
35. [35] Koul, P.A., Ahmad, S.H., Ahmad, F., Jan, R.A., Shah, S.U., Khan, U.H., Vitamin D toxicity in adults: a case series from an area with endemic hypovitaminosis D. Oman Med J 26 (2011), 201–204.
36. [36] Sanders, K.M., Stuart, A.L., Williamson, E.J., Simpson, J.A., Kotowicz, M.A., Young, D., et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 303 (2010), 1815–1822.
37. [37] Kearns, M.D., Alvarez, J.A., Tangpricha, V., Large, single-dose, oral vitamin D supplementation in adult populations: a systematic review. Endocr Pract 20 (2014), 341–351.
38. [38] Smith, H., Anderson, F., Raphael, H., Maslin, P., Crozier, S., Cooper, C., Effect of annual intramuscular vitamin D on fracture risk in elderly men and women: a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology 46 (2007), 1852–1857.
39. [39] Romagnoli, E., Pepe, J., Piemonte, S., Cipriani, C., Minisola, S., Management of endocrine disease: value and limitations of assessing vitamin D nutritional status and advised levels of vitamin D supplementation. Eur J Endocrinol 169 (2013), R59–R69.
40. [40] Masood, M.Q., Khan, A., Awan, S., Dar, F., Naz, S., Naureen, G., et al. Comparison of vitamin-D replacement strategies with high-dose intramuscular or oral cholecalciferol: a prospective intervention study. Endocr Pract 21 (2015), 1125–1133.
41. [41] Bothra, M., Gupta, N., Jain, V., Effect of intramuscular cholecalciferol megadose in children with nutritional rickets. J Pediatr Endocrinol Metab 29 (2016), 687–692.
42. [42] Jones, G., Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr 88 (2008), 582–586.
43. [43] Vogiatzi, M.G., Jacobson-Dickman, E., DeBoer, M.D., Drugs and Therapeutics Committee of the Pediatric Endocrine Society. Vitamin D supplementation and risk of toxicity in pediatrics: a review of current literature. J Clin Endocrinol Metab 99 (2014), 1132–1141.